Pharmaceuticals and Healthcare Reports Liver Cancer Market

Liver Cancer Market Trends and Pipeline
Review 2016
“Liver cancer starts in the liver. The risk factors for
liver cancer include hepatitis, cirrhosis, or scarring
of liver, being male and having low weight at birth.”
Summary
The Report provides an overview of the Liver Cancer (Oncology) pipeline landscape.
Liver cancer starts in the liver. The risk factors for liver cancer include hepatitis, cirrhosis, or
scarring of liver, being male and having low weight at birth. Symptoms include a lump or pain on
the right side of the abdomen and yellowing of the skin. Treatment of liver cancer may include
chemotherapy, radiation and surgery.
Complete Report Available @ http://www.radiantinsights.com/research/liver-cancer-
pipeline-review-h2-2016
Report Highlights
Radiant Insights's Pharmaceutical and Healthcare latest pipeline guide Liver Cancer - Pipeline
Review, H2 2016, provides comprehensive information on the therapeutics under development for
Liver Cancer (Oncology), complete with analysis by stage of development, drug target, mechanism
of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive
pharmacological action of the therapeutics, its complete research and development history and
latest news and press releases.
Follow Us: